NASDAQ:MGTX MeiraGTx (MGTX) Stock Price, News & Analysis $6.13 -0.23 (-3.62%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$6.29 +0.16 (+2.54%) As of 04/3/2025 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About MeiraGTx Stock (NASDAQ:MGTX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MeiraGTx alerts:Sign Up Key Stats Today's Range$5.87▼$6.2550-Day Range$6.09▼$8.2552-Week Range$3.85▼$8.75Volume1.10 million shsAverage Volume295,150 shsMarket Capitalization$483.38 millionP/E RatioN/ADividend YieldN/APrice Target$24.50Consensus RatingBuy Company OverviewMeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.Read More… Remove Ads MeiraGTx Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks94th Percentile Overall ScoreMGTX MarketRank™: MeiraGTx scored higher than 94% of companies evaluated by MarketBeat, and ranked 46th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingMeiraGTx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMeiraGTx has only been the subject of 2 research reports in the past 90 days.Read more about MeiraGTx's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for MeiraGTx are expected to grow in the coming year, from ($1.48) to $0.38 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MeiraGTx is -5.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MeiraGTx is -5.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioMeiraGTx has a PEG Ratio of 0.37. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioMeiraGTx has a P/B Ratio of 2.82. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about MeiraGTx's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.74% of the float of MeiraGTx has been sold short.Short Interest Ratio / Days to CoverMeiraGTx has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in MeiraGTx has recently decreased by 1.01%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMeiraGTx does not currently pay a dividend.Dividend GrowthMeiraGTx does not have a long track record of dividend growth. Sustainability and ESG4.8 / 5Environmental Score-0.54 Percentage of Shares Shorted2.74% of the float of MeiraGTx has been sold short.Short Interest Ratio / Days to CoverMeiraGTx has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in MeiraGTx has recently decreased by 1.01%, indicating that investor sentiment is improving. News and Social Media4.0 / 5News Sentiment1.16 News SentimentMeiraGTx has a news sentiment score of 1.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for MeiraGTx this week, compared to 2 articles on an average week.Search Interest3 people have searched for MGTX on MarketBeat in the last 30 days. MarketBeat Follows2 people have added MeiraGTx to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, MeiraGTx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $382,838.00 in company stock.Percentage Held by InsidersOnly 8.40% of the stock of MeiraGTx is held by insiders.Percentage Held by Institutions67.48% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about MeiraGTx's insider trading history. Receive MGTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter. Email Address MGTX Stock News HeadlinesChardan Capital Predicts MeiraGTx FY2025 EarningsMarch 28, 2025 | americanbankingnews.comMeiraGTx Holdings: Gaining Regulatory FocusMarch 25, 2025 | seekingalpha.comThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.April 4, 2025 | Colonial Metals (Ad)MeiraGTx Holdings plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near FutureMarch 24, 2025 | finance.yahoo.comMeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s TreatmentMarch 18, 2025 | msn.comMeiraGTx price target raised to $13 from $11 at RBC CapitalMarch 17, 2025 | markets.businessinsider.comMeiragtx Holdings (MGTX) Gets a Buy from Evercore ISIMarch 17, 2025 | markets.businessinsider.comMEIRAGTX HOLDINGS Earnings Results: $MGTX Reports Quarterly EarningsMarch 15, 2025 | nasdaq.comSee More Headlines MGTX Stock Analysis - Frequently Asked Questions How have MGTX shares performed this year? MeiraGTx's stock was trading at $6.09 at the start of the year. Since then, MGTX stock has increased by 0.7% and is now trading at $6.13. View the best growth stocks for 2025 here. How were MeiraGTx's earnings last quarter? MeiraGTx Holdings plc (NASDAQ:MGTX) issued its quarterly earnings data on Thursday, March, 13th. The company reported ($0.50) earnings per share for the quarter, missing analysts' consensus estimates of ($0.48) by $0.02. The business had revenue of $21.39 million for the quarter, compared to analysts' expectations of $1.50 million. MeiraGTx had a negative trailing twelve-month return on equity of 146.38% and a negative net margin of 633.05%. When did MeiraGTx IPO? MeiraGTx (MGTX) raised $75 million in an IPO on Friday, June 8th 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI served as the underwriters for the IPO and Chardan was co-manager. How do I buy shares of MeiraGTx? Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MeiraGTx own? Based on aggregate information from My MarketBeat watchlists, some other companies that MeiraGTx investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Moderna (MRNA). Company Calendar Last Earnings3/13/2025Today4/03/2025Next Earnings (Estimated)5/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:MGTX CIK1735438 Webwww.meiragtx.com Phone(646) 860-7985FaxN/AEmployees300Year FoundedN/APrice Target and Rating Average Stock Price Target$24.50 High Stock Price Target$36.00 Low Stock Price Target$13.00 Potential Upside/Downside+299.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($2.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth0.37Net Income$-84,030,000.00 Net Margins-633.05% Pretax Margin-633.05% Return on Equity-146.38% Return on Assets-53.05% Debt Debt-to-Equity Ratio0.86 Current Ratio2.34 Quick Ratio2.34 Sales & Book Value Annual Sales$33.28 million Price / Sales14.53 Cash FlowN/A Price / Cash FlowN/A Book Value$2.17 per share Price / Book2.82Miscellaneous Outstanding Shares78,855,000Free Float71,588,000Market Cap$483.38 million OptionableOptionable Beta1.21 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:MGTX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MeiraGTx Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share MeiraGTx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.